Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Elvitegravir |
EINECS | 1592732-453-0 |
CAS No. | 697761-98-1 | Density | 1.357 g/cm3 |
PSA | 88.76000 | LogP | 4.28100 |
Solubility | N/A | Melting Point |
93-96°C |
Formula | C23H23ClFNO5 | Boiling Point | 623.6 °C at 760 mmHg |
Molecular Weight | 447.88 | Flash Point | 330.9 °C |
Transport Information | N/A | Appearance | N/A |
Safety | Risk Codes | N/A | |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
Elvitegravir;GS-9137,JTK-303; |
Article Data | 15 |
This chemical is called Elvitegravir, and its systematic name is 3-Quinolinecarboxylic acid, 6-((3-chloro-2-fluorophenyl)methyl)-1,4-dihydro-1-((1S)-1-(hydroxymethyl)-2-methylpropyl)-7-methoxy-4-oxo-. With the molecular formula of C23H23ClFNO5, its molecular weight is 447.88. The CAS registry number of this chemical is 697761-98-1. Additionally, its classification code is Treatment of HIV-1 infections.
Other characteristics of the Elvitegravir can be summarised as followings: (1)ACD/LogP: 4.29; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 3.7; (4)ACD/LogD (pH 7.4): 1.95; (5)ACD/BCF (pH 5.5): 275.77; (6)ACD/BCF (pH 7.4): 4.86; (7)ACD/KOC (pH 5.5): 1319.21; (8)ACD/KOC (pH 7.4): 23.24; (9)#H bond acceptors: 6; (10)#H bond donors: 2; (11)#Freely Rotating Bonds: 8; (12)Polar Surface Area: 65.07 Å2; (13)Index of Refraction: 1.603; (14)Molar Refractivity: 113.33 cm3; (15)Molar Volume: 329.9 cm3; (16)Polarizability: 44.93×10-24cm3; (17)Surface Tension: 55 dyne/cm; (18)Density: 1.357 g/cm3; (19)Flash Point: 330.9 °C; (20)Enthalpy of Vaporization: 97.09 kJ/mol; (21)Boiling Point: 623.6 °C at 760 mmHg; (22)Vapour Pressure: 2.06E-16 mmHg at 25°C.
You can still convert the following datas into molecular structure:
1.SMILES: Clc1cccc(c1F)Cc3c(OC)cc2c(C(=O)\C(=C/N2[C@H](CO)C(C)C)C(=O)O)c3
2.InChI: InChI=1/C23H23ClFNO5/c1-12(2)19(11-27)26-10-16(23(29)30)22(28)15-8-14(20(31-3)9-18(15)26)7-13-5-4-6-17(24)21(13)25/h4-6,8-10,12,19,27H,7,11H2,1-3H3,(H,29,30)/t19-/m1/s1
3.InChIKey: JUZYLCPPVHEVSV-LJQANCHMBZ